Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-029397
Filing Date
2015-05-11
Accepted
2015-05-11 17:15:40
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v407017_10q.htm 10-Q 352169
2 EXHIBIT 10.1 v407017_ex10-1.htm EX-10.1 232464
3 EXHIBIT 31.1 v407017_ex31-1.htm EX-31.1 8240
4 EXHIBIT 31.2 v407017_ex31-2.htm EX-31.2 8158
5 EXHIBIT 32.1 v407017_ex32-1.htm EX-32.1 5007
  Complete submission text file 0001144204-15-029397.txt   7196530

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT icpt-20150331.xml EX-101.INS 1543042
7 XBRL TAXONOMY EXTENSION SCHEMA icpt-20150331.xsd EX-101.SCH 33709
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20150331_cal.xml EX-101.CAL 33126
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20150331_def.xml EX-101.DEF 84629
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20150331_lab.xml EX-101.LAB 247714
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20150331_pre.xml EX-101.PRE 202350
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 15851806
SIC: 2834 Pharmaceutical Preparations